GJWM
BIIB icon

Gilliland Jeter Wealth Management’s Biogen BIIB Stock Holding History

Gilliland Jeter Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-460
Closed -$89.2K – 221
2024
Q3 		$89.2K Hold
460
– – 0.03% 234
2024
Q2 		$107K Hold
460
– – 0.04% 208
2024
Q1 		$99.2K Buy
+460
New +$108K 0.03% 218

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Gilliland Jeter Wealth Management's BIIB Position: Q4 2024 in Review

Gilliland Jeter Wealth Management sold out of Biogen (BIIB) in Q4 2024, closing a stake of 460 shares — an estimated $89.2K sold.

Gilliland Jeter Wealth Management first reported a position in BIIB in Q1 2024 and held it in 3 quarters. The position peaked at $107K in Q2 2024. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Gilliland Jeter Wealth Management reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Gilliland Jeter Wealth Management sold 460 Biogen shares in Q4 2024, an estimated $89.2K.
  • Gilliland Jeter Wealth Management first reported a position in Biogen in Q1 2024 and held it in 3 quarters.
  • Gilliland Jeter Wealth Management's Biogen position peaked at $107K in Q2 2024.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Gilliland Jeter Wealth Management's 13F filing for Q4 2024, filed 28 Jan 2025.